The White House tenant says he will announce the levies against pharmacists “in the next two weeks”
MADRID, 6 May. (EUROPA PRESS) –
The president of the United States, Donald Trump, signed on Monday an executive order to boost the national manufacture of medicines against possible tariffs against pharmaceuticals, after threatening with an “important” taxes to companies with the aim of returning their production to the country.
Through the document, Trump has ordered the Food and Medicines Administration (FDA) to reduce the time to approve national plants of manufacturing pharmaceutical products “eliminating duplicate and unnecessary requirements, expediting revisions and working with national manufacturers to provide early support before the facilities enter into operation.”
“Trump is eliminating bureaucratic obstacles to the national manufacture of critical pharmaceutical products in order to mark the beginning of a new golden era in the United States by guaranteeing access to medications that Americans need. There are still barriers and critical gaps to establish a national, resilient and affordable pharmaceutical supply chain for US patients,” says the text.
He has also asked the FDA to increase rates and inspections to foreign manufacturing plants. From the Oval Office, the White House tenant has confirmed that it will announce the details of the tariffs against pharmacists “in the next two weeks.”
Related news :